chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Subject reports that at approximately 5:00 pm on 10-8-08 he experienced general muscle aches, fatigue and fever. He experienced two episodes of shortness of breath, dry throat and cough on 10-9-08. He also reportedly experienced profound fatigue in the morning of 10-9-08 and missed work. Treated the symptoms with Tylenol and rest. All symptoms resolved on 10-10-08.
Pt. states that after receiving the 3rd Booster of Moderna 11/03/2021, started experiencing symptoms 11/13/2021 of Skin rash on the face and head, Emergency Room visit 11/13/2021, hives back of the head, swollen throat  Steroid shot given.11/15/2021 hives on the head and between the legs, swollen throat, Primary visit 11/16/2021 treated with steroid shot. Still experiencing symptoms.
Lower birth weight; This spontaneous case was reported by a consumer and describes the occurrence of LOW BIRTH WEIGHT BABY (Lower birth weight) in a foetus patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The mother's past medical history included Maternal exposure during pregnancy.    No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Transplacental) 1 dosage form. On an unknown date, the patient experienced LOW BIRTH WEIGHT BABY (Lower birth weight). At the time of the report, LOW BIRTH WEIGHT BABY (Lower birth weight) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Transplacental) was unknown.       No concomitant medications are provided.  No treatment medications are provided.  3 months post partum the mother and the baby were doing well. No health issues.  This case concerns a foetus of unknown gender and age with no details on relevant medical history, who experienced the unexpected event of Low birth weight baby after transplacental exposure of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine. The mother of the patient received the dose of the vaccine at an unknown stage of gestation and the delivery occurred on an unknown date at an unknown stage of gestation. Very limited information has been provided. The rechallenge is not applicable due to the nature of the event. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-364886 (Parent-Child Link).   See case MOD-2021-364886 for details regarding the child case.; Sender's Comments: This case concerns a foetus of unknown gender and age with no details on relevant medical history, who experienced the unexpected event of Low birth weight baby after transplacental exposure of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine. The mother of the patient received the dose of the vaccine at an unknown stage of gestation and the delivery occurred on an unknown date at an unknown stage of gestation. Very limited information has been provided. The rechallenge is not applicable due to the nature of the event. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Mass on left thigh still present 3 + months after the PEDARIX (Dtap/HepB/IPV) vaccine was given.
Post vax, 12 to 14 hours, pt developed fine urticarial rash on face and buttocks. Pt constantly scratching. Had 2 episodes of vomiting and mushy stool X 1.
Patient's left shoulder and left elbow became sore  about one week after receiving vaccine in right arm.
Very red, large area, hot to touch. Whole arm looks red. Couple days later it happened.
Achiness and discomfort in spine and neck.  Sinus pressure in ears.  headache.  Generally not feeling well.
Pt presents c/o pain in his A/C joint and the ribs along the side of the sternum starting shortly after his second dose of Pfizer vaccine. Sx have persisted now for ~6 weeks. He had an injury to both areas in a motorcycle accident ~3 years ago but had fully recovered and had no pain until recently. He denies new injury, redness, swelling, bruising. He has tried OTC pain meds without relief.  Assessment/Plan  Costochondral chest pain/Arthralgia of left acromioclavicular joint -     meloxicam (MOBIC) 15 MG tablet; Take 1 tablet by mouth daily. -     Consider ortho referral if not improving.  -     Sx began soon after second Pfizer dose, will report as possible vaccine reaction
Prolonged  (4-5 hours) fever of 103.5, unable to control with motrin or tylenol. Swelling pain and redness at injection site. Swollen lymph nodes. Temp of 99.5 for two days after
symptoms begin on 08/02/21 fatigue, headache, sore throat, congestion, runny nose
Passed out, threw up myself while passed out went into convulsions.  Ambulance/EMTs were called.
From time of shot severe pain in arm running up the neck and down arm, severely tired with flu like sysmptoms. Twenty days lter still have severe pain in arm, very hard to use!!!
Redness and swelling of left arm two days following getting vaccinations.RX of Sulfamethoxazole-Trimethoprim 200mg-40mg/5ml oral suspension. 5mL Oral 2 times a day for 10 days
Patient received Rotateq on 11-13-06 and 5 days later had bilious emesis. Seen in ED, had (-) upper gastrointestinal.  Also with diarrhea. Also has milk protein sensitivity.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/1/2022 Discharge Date: Oct 3, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1]   HOSPITAL COURSE: Patient is a 75 y.o. male with a pertinent past medical history of prostate cancer s/p TURP 2017, infected nephrolithiasis with Klebsiella and enterococcus UA, with klebsiella bacteremia and septic shock January 2022, s/p nephrostomy tube placement, Chronic diastolic CHF, severe AV stenosis s/p TAVR 4/5/22, arthritis s/p bilateral knee, right hip, right shoulder replacement, medically refractory Parkinson's disease, with recent admission for deep brain stimulation lead implantation with foley placement, who presented with generalized weakness, fatigue, urinary frequency found to have a complicated UTI with E. Coli Bacteremia noted on admission. Patient was given 2 days of Rocephin prior to discharge, as blood culture susceptibilities came back on 10/3, with notable susceptibility to ciprofloxacin. Patient is planned to be discharged with 8 days more of ciprofloxacin to complete a total 10d course. Patient was originally planned for generator placement for DBS during admission, but due to infection neurosurg declined intervention at this time with ongoing infection. He was also found to have a small left possible renal calculus on ultrasound. His symptoms resolved and patient was discharged on 10-/3 hemodynamically stable. All questions were answered prior to discharge, and patient was set up with his urologist OP for follow up planned 10/14.
Dizziness, Headache, Sedation, Myalgia, Fever, NauseaVomiting, chills and fatigue. pain, redness and swelling at the injection
redness /at injection site; swelling at injection site; fever; chills; weakness; flu-like symptoms; first dose /December 2020/ second dose August 6, 2021.; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (had swelling, fever, chills, weakness after receiving 1st dose in December 2020, for tolerance refer case US2021AMR169451).   On 6th August 2021, the patient received the 2nd dose of Shingrix. On 6th August 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced injection site erythema, injection site swelling, fever, chills, weakness and influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site erythema, injection site swelling, fever, chills, weakness and influenza-like symptoms were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling, fever, chills, weakness and influenza-like symptoms to be related to Shingrix.  Additional details provided were as follows: Age at vaccination was not reported. The patient received the second dose of Shingrix on left deltoid and after 12 hours experienced redness and swelling at injection site, fever, chills, weakness and flu like symptoms. He had not recovered yet from those symptoms and stated his fever comes and went for the last four days. He also mentioned that he had the same symptoms with the first dose but the symptoms went away after a few days. The reporter referred him to health care professional. Limited information was obtained. The reporter did not consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR169451:1st dose, Same reporter
10:30am mother called stated irritable restless and not sleeping during night. Pounding rapid heartbeat. Had just gotten child to sleep. Had given Tylenol and Benadryl night. 4pm mother if office-baby seen by MD-admitted to hospital for observation. MD stated prob reaction to Prevnar. Family history of asthma-dx. asthma vs. prea. The discharge summary received on 3/23/04 states bronchiolitis and otitis media.
Shoulder pain; Tenderness under the biceps; This is a spontaneous case, initially received from other health professional on 20-Nov-2018, concerning a 54-year-old, adult, female patient.  The patient had no medical history. The patient did not receive any concomitant medications.  On 09-Oct-2018, the patient was administered Flucelvax QIVc [influenza vaccine, subunit influenza virus vaccine polyvalent, cell-culture derived, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252663 and expiry date: 31-May-2019] for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.  On an unspecified date in 2018, few days later after vaccination, the patient experienced shoulder pain and tenderness under the biceps. The patient had no redness and swelling. It was reported that, the patient felt better.  At the time of this report, the patient was recovering from the events.  This case is linked to case 201805709 (same reporter).  The reporter assessed the case as non-serious.; Reporter's Comments: A 54-year-old, female patient developed shoulder pain and tenderness on an unspecified in 2018, after administration of Flucelvax QIVc vaccine. The causality of the events was unassessable due to lack of information regarding the onset latency of the events. The case will be further assessed upon receipt of follow up information.
Pneumonia; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 17Feb2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pneumonia in Feb2021. It was reported that the patient received the vaccine on 17Feb2021 and questioned what would happen if a person has pneumonia after the vaccine, which required antibiotic therapy for 11 days. Therapeutic measures were taken as a result of the event, which included unspecified antibiotic therapy starting 24Feb2021. The clinical outcome of pneumonia was unknown.  The lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: PATIENT FELT TINGLING IN HER LEG,THEN NUMBNESS IN HER ARM-911 WAS CALL AND PATIENT LEFT WITH PARAMEDIC
Tinnitus,  tingling and crackling  on the top of head/brain,  lip and facial tingling and numbness (similar to Novocaine), headache, arm soreness, and nausea.
Elbow pain, 1 day, post vax. Neck pain, 2 days, post vax. Diffuse arthralgias and myalgia 5 to 6 days, post vax, persisting to 11 days, post vax. Swelling MCP joints on bilateral hands at 5 to 6 days and fatigue.
BRUISES ON MIDDLE OF FOREHEAD, EYEBROWS AND LEFT EYE WHICH HURTS; This spontaneous report received from a consumer concerned a 26 year old male. The patient's weight was 180 pounds, and height was 75 inches. The patient's concurrent conditions included: smoker, non-alcohol user, and bipolar, and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: UNKNOWN) dose was not reported, administered on 09-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-AUG-2021, the patient experienced bruises on middle of forehead, eyebrows and left eye which hurts. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from bruises on middle of forehead, eyebrows and left eye which hurts. This report was non-serious.
In November 2022 after the 5th dose, I was diagnosed with Rhino Virus. My symptoms were a violent cough and difficulty breathing. The virus lasted for three weeks, and I lost my voice for even longer. I visited the emergency room, and I was prescribed gel pills. March 10th 2023 I felt pressure on my diaphragm for two days. It felt like someone had punched me in my gut. At the end of March, I was having a hard time breathing and went back to the emergency department. They saw fluid in my lung, gave me antibiotics and sent me home. April 7th I was unable to breath and went back to the emergency room. They found that I was in congestive heart failure and was admitted to the hospital. I was assigned a cardiologist and put me on LASIX and food restriction. After walking around the hospital, I woke up and was told that I had had a stroke on March 9th or 10th. I was admitted to ICU. As a result of the stroke, I lost my left peripheral vision. That part of my brain is brain dead, and my vision cannot be restored.
I was given the shot too early.  My first shot was on 01/15/2021 and I received my second shot on 02/02/2021.  I have since learned they need to be given 28 day apart with a four day window either way.  When I was alerted by email that I could sign up for my second shot, I took the soonest slot I could get in fear of the county running out of vaccinations.  There should have been some kind of default set up so that I was not able to sign up for the vaccine too early.  Accounting for the four day window, I got the shot 6 days too soon.  Will my vaccines work due to the fact that I received the second too early?
COVID arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE REACTION (COVID arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm). At the time of the report, VACCINATION SITE REACTION (COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported Treatment information was not provided.
My 5 year old daughter received the COVID vaccine 2nd dose 12/12/2021 at 11 AM. By 11 PM  12/12/2021 she had a high fever for 5 days, difficult urinating and a rash. At the hospital and she is now being transferred to another hospital because RBC low, WBC low, platelets low, etc.
Temp excursion/beyond use date excursion I called about on1/21/22.; Temp excursion/beyond use date excursion I called about on1/21/22.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Temp excursion/beyond use date excursion I called about on1/21/22.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temp excursion/beyond use date excursion I called about on1/21/22.) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Temp excursion/beyond use date excursion I called about on1/21/22.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temp excursion/beyond use date excursion I called about on1/21/22.). On 20-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Temp excursion/beyond use date excursion I called about on1/21/22.) had resolved. At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temp excursion/beyond use date excursion I called about on1/21/22.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported. No treatment information was provided.
3 minutes later he almost fainted after getting the vaccine; shortness of breath; sweating profusely; cold all over the body; felt like he was about to explode; left arm was sore; headaches on both sides of the head; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (3 minutes later he almost fainted after getting the vaccine), DYSPNEA (shortness of breath), HYPERHIDROSIS (sweating profusely), FEELING COLD (cold all over the body) and FEELING ABNORMAL (felt like he was about to explode) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DIZZINESS (3 minutes later he almost fainted after getting the vaccine), DYSPNEA (shortness of breath), HYPERHIDROSIS (sweating profusely), FEELING COLD (cold all over the body), FEELING ABNORMAL (felt like he was about to explode), VACCINATION SITE PAIN (left arm was sore) and HEADACHE (headaches on both sides of the head). On 03-Apr-2021, VACCINATION SITE PAIN (left arm was sore) had resolved. At the time of the report, DIZZINESS (3 minutes later he almost fainted after getting the vaccine), DYSPNEA (shortness of breath), HYPERHIDROSIS (sweating profusely), FEELING COLD (cold all over the body), FEELING ABNORMAL (felt like he was about to explode) and HEADACHE (headaches on both sides of the head) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Water was the Treatment Medication.  The patient received the vaccine at 9:30am and stated exactly 3 minutes later he almost fainted after getting the vaccine. He started to experience shortness of breath, cold all over the body like when you are about to faint and sweating profusely; His left arm was sore for next 2-3 days and has also been having headaches on both sides of the head. He stated after he started sweating he asked the nurse for some water and felt better after drinking water.  Company comment: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Painful swelling in underarm and clavicle area, left side of body, same side as injection site.
I started having Migraines, which then started seizure like activity is what they are calling it as they are still trying to figure out what is going on. Medications for the migraines are; Amitriptlyline, Naratriptan, Propanolol, and Riboflavin, also getting botox injections. Medications for the 'seizure like activity' is 2 that i was already on is Lamictal (bipolar and mood swings) and Neurontin (nerve damage in back). I am also in the process to confirm if i have P.O.T.S. I am also being treated for Fibromyalgia. Medications are Neurontin and Flexiril. so on top of the other health issues I already have, I am having to deal with all of this now too.
10/31/07 some body aches, neck stiffness. 11/1/07 PM - fever, stiff neck, headache, 11/2/07 Temp 101.4l, stiff neck, headache.
Bell's Palsy, myalgia & neck pain are reported in pt who recvd flu vax/pneumococcal vax; pt also recvd insulin; On 6OCT90 pt devel bell's palsy; prior to onset of bell's palsy pt had some myalgia & not feeling right; also paralysi
Patient described left shoulder pain around the area of the injection.  That progressed to pain localized to shoulder and then to weakness in the left shoulder over a period of several weeks.
Reddening of Bicep, itchiness, swelling and hardening of area 2-5 inches around injection site. Extremely Hot and Painful in the entire bicep.
None- vaccine given 17 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 17 days post expiry) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 17 days post expiry). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 17 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.   This case was linked to MOD-2021-395985 (Patient Link).
increased heart rate, tingling, metalic taste, blurry vision night following having Shingrix and fatigue for the next day, reported her symptoms to dr who advised her not to receive another dose.
fatigue, runny nose, decreased taste, decreased smell.  Positive PCR on 07/30/2021
Case number PHEH2012US017116 is an initial spontaneous report received from a nurse on 29 Aug 2012. This report refers to a 12-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A11052, and expiry date: Mar 2014) 0.5 ml intramuscularly on 27 Aug 2012. On unspecified date the patient had injection site reaction. The injection site was raised, hard, sore, red and swollen. The outcome was not reported.
Employee became diaphoretic, stated he felt his heart was racing, and that he was very anxious. Stated he has history of fear of needles.  He also does extreme exercise program. Evaluated by EMT's BP 152/97, HR 56, SpO2 100% After 15 extra minutes observation employee stated he felt fine to go to work.